Company Search:
Advanced Search
Sponsored Links
Diasorin S.P.A. Company Snapshot
Diasorin S.P.A. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Diasorin S.P.A. with three other pharmaceutical manufacturers in Europe: Swedish Orphan Biovitrum AB (publ) of Sweden (2017 sales of 6.51 billion Swedish Kronor [US$794.73 million] ), Siegfried Holding AG of Switzerland (750.47 million Swiss Francs [US$788.31 million] of which 77% was Drug Substances), and Almirall SA which is based in Spain (639.38 million Euro [US$785.48 million] of which 71% was Own Network (Spain)).

Sales Analysis. During the year ended December of 2017, sales at Diasorin S.P.A. were 637.50 million Euro (US$783.17 million). This is an increase of 12.0% versus 2016, when the company's sales were 569.31 million Euro. This was the fifth consecutive year of sales increases at Diasorin S.P.A. (and since 2012, sales have increased a total of 47%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Diasorin S.P.A.
  Stock Performance Chart for Diasorin S.P.A.
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 72.20
(Figures in Euro)
1 Week -3.4%   13 Weeks 1.3%  
4 Weeks -4.7%   52 Weeks 17.7%  
Diasorin S.P.A. Key Data:
  Ticker: DIA Country: Italy
  Exchanges: ISE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 637,500,000
(Year Ending Jan 2018).
Employees: 1,841
  Currency: Euro Market Cap: 3,953,549,765
  Fiscal Yr Ends: December Shares Outstanding: 54,758,307
  Share Type: Azioni Ordinaire Closely Held Shares: 31,943,658
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.